Yuval Cohen
Algemeen Directeur bij CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermogen: 3 M $ op 31-05-2024
Actieve functies van Yuval Cohen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Bestuurslid | 11-04-2014 | - |
| Algemeen Directeur | 11-04-2014 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Directeur/Bestuurslid | 01-07-2013 | - |
| Algemeen Directeur | 01-07-2013 | - |
Loopbaan van Yuval Cohen
Eerdere bekende functies van Yuval Cohen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 01-01-2005 | 01-02-2013 |
| Oprichter | 01-01-2005 | 01-12-2013 | |
| Corporate Officer/Principal | 01-02-2013 | 01-12-2013 | |
| President | 01-01-2005 | 01-02-2013 |
Opleiding van Yuval Cohen
| University of Cape Town | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
| Zuid-Afrika | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
- Beurs
- Insiders
- Yuval Cohen
- Ervaring
